BON — Stock Film
STOCK FILMSCENE 1/11BON · $1.15
Stock Expert AI presents
BON
Bon Natural Life Limited
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Bon Natural Life Limited. A quick introduction.

On the stock market since 2021, it operates in the world of raw materials. It has 96 employees. Now — the numbers.

on the stock market since 2021
96 employees
$6.8M market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $1.1.

The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.

WHERE DOES THE MONEY COME FROM?
43%Fragrance Compounds
Fragrance Compounds 43%Bioactive Food Ingredients 39%Health Supplements (Solid Drinks) 18%
43% of all revenue comes from a single line: Fragrance Compounds.

Revenue is spread across several lines; no single product carries the company.

THE SALES TREND
Sales have been shrinking.

An average decline of 7% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.

$25.5M
2021
$29.9M
2022
$29.5M
2023
$23.8M
2024
$18.7M
2025
In the vault right now:
$0
DEBT: $12.3M
At this pace, that money lasts about 3.1 years.

Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 3 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
The stock has lost its spark0/10
Growth has stalled2/10
Little set aside for the future2/10
WORTH WATCHING

Revenue Growth: Sales are growing slowly.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/1
The product is selling

Sales run at $18.7M a year. A small number, but proof the product has real buyers.

1
THE RISKS · 1/3
Running at a loss

A loss of $2.0M against $18.7M in annual sales. And on top of that, sales fell from the year before.

2
THE RISKS · 2/3
The stock has lost its spark

Since the drop from its peak, buyer appetite hasn’t come back. Council score: 0/10.

3
THE RISKS · 3/3
Growth has stalled

The sales tempo runs behind the sector. Council score: 2/10.

FINALE · THE GRADE
D
0 / 100 · MoonshotScore

On our five-subject report card, BON sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: BON is a high-risk stock — not yet profitable, and its future rides on its product catching on.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film